Measurement of hepatic drug-metabolizing enzyme activity in man
- 1 January 1980
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 17 (4) , 267-274
- https://doi.org/10.1007/bf00625800
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Impairment of drug metabolism in patients with liver cancerEuropean Journal of Clinical Investigation, 1977
- Factors influencing antipyrine elimination.British Journal of Clinical Pharmacology, 1977
- Phenobarbitone-induced urinary excretions of D-glucaric acid and 6β-hydroxycortisol in manCanadian Journal of Physiology and Pharmacology, 1976
- Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man.Published by Wiley ,1975
- Clearance of Antipyrine‐Dependence of Quantitative Liver FunctionEuropean Journal of Clinical Investigation, 1974
- Clearance of Antipyrine‐Dependence of Quantitative Liver FunctionEuropean Journal of Clinical Investigation, 1974
- Determinants of serum antipyrine half-lives in patients with liver diseaseGut, 1973
- URINARY D-GLUCARIC-ACID EXCRETION AS A TEST FOR HEPATIC ENZYME INDUCTION IN MANThe Lancet, 1971
- The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 hemes in the ratBiochimica et Biophysica Acta (BBA) - General Subjects, 1970
- Metabolism of Drugs in Subjects with Laennec’s CirrhosisPharmacology, 1959